QQQ   281.00 (-2.31%)
AAPL   142.47 (-2.84%)
MSFT   244.49 (-2.28%)
META   114.45 (-6.52%)
GOOGL   96.89 (-2.60%)
AMZN   88.43 (-2.83%)
TSLA   179.12 (-1.83%)
NVDA   159.13 (-4.20%)
NIO   13.20 (+3.13%)
BABA   91.01 (+0.54%)
AMD   69.87 (-5.09%)
T   19.07 (+1.71%)
MU   53.40 (-1.18%)
CGC   3.61 (-16.44%)
F   13.15 (-1.72%)
GE   84.70 (+0.05%)
DIS   92.43 (-3.65%)
AMC   6.79 (-8.86%)
PYPL   71.82 (-2.44%)
PFE   49.70 (-2.03%)
NFLX   304.14 (-2.70%)
QQQ   281.00 (-2.31%)
AAPL   142.47 (-2.84%)
MSFT   244.49 (-2.28%)
META   114.45 (-6.52%)
GOOGL   96.89 (-2.60%)
AMZN   88.43 (-2.83%)
TSLA   179.12 (-1.83%)
NVDA   159.13 (-4.20%)
NIO   13.20 (+3.13%)
BABA   91.01 (+0.54%)
AMD   69.87 (-5.09%)
T   19.07 (+1.71%)
MU   53.40 (-1.18%)
CGC   3.61 (-16.44%)
F   13.15 (-1.72%)
GE   84.70 (+0.05%)
DIS   92.43 (-3.65%)
AMC   6.79 (-8.86%)
PYPL   71.82 (-2.44%)
PFE   49.70 (-2.03%)
NFLX   304.14 (-2.70%)
QQQ   281.00 (-2.31%)
AAPL   142.47 (-2.84%)
MSFT   244.49 (-2.28%)
META   114.45 (-6.52%)
GOOGL   96.89 (-2.60%)
AMZN   88.43 (-2.83%)
TSLA   179.12 (-1.83%)
NVDA   159.13 (-4.20%)
NIO   13.20 (+3.13%)
BABA   91.01 (+0.54%)
AMD   69.87 (-5.09%)
T   19.07 (+1.71%)
MU   53.40 (-1.18%)
CGC   3.61 (-16.44%)
F   13.15 (-1.72%)
GE   84.70 (+0.05%)
DIS   92.43 (-3.65%)
AMC   6.79 (-8.86%)
PYPL   71.82 (-2.44%)
PFE   49.70 (-2.03%)
NFLX   304.14 (-2.70%)
QQQ   281.00 (-2.31%)
AAPL   142.47 (-2.84%)
MSFT   244.49 (-2.28%)
META   114.45 (-6.52%)
GOOGL   96.89 (-2.60%)
AMZN   88.43 (-2.83%)
TSLA   179.12 (-1.83%)
NVDA   159.13 (-4.20%)
NIO   13.20 (+3.13%)
BABA   91.01 (+0.54%)
AMD   69.87 (-5.09%)
T   19.07 (+1.71%)
MU   53.40 (-1.18%)
CGC   3.61 (-16.44%)
F   13.15 (-1.72%)
GE   84.70 (+0.05%)
DIS   92.43 (-3.65%)
AMC   6.79 (-8.86%)
PYPL   71.82 (-2.44%)
PFE   49.70 (-2.03%)
NFLX   304.14 (-2.70%)
NASDAQ:MBII

Marrone Bio Innovations - MBII Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$0.80
▼
$0.80
50-Day Range
$0.80
▼
$0.80
52-Week Range
$0.55
▼
$1.55
Volume
38 shs
Average Volume
919,497 shs
Market Capitalization
$145.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.30

Marrone Bio Innovations MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
62.9% Upside
$1.30 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-11.74
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.06) to ($0.02) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.44 out of 5 stars

Basic Materials Sector

153rd out of 163 stocks

Agricultural Chemicals Industry

9th out of 9 stocks

See Top Rated MarketRank™ Stocks Here
MBII stock logo

About Marrone Bio Innovations (NASDAQ:MBII) Stock

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

MBII Stock News Headlines

November 18, 2022 | finance.yahoo.com
Nanopesticide Market Report 2022: Featuring Andermatt Biocontrol, Bayer, Corteva, Marrone Bio Innovations & More
October 18, 2022 | marketwatch.com
Agricultural Microbials Market Size, Share, Regional Growth Analysis, Industry Outlook and Forecast 2022-2029
October 16, 2022 | msn.com
MBI investigating officer-involved shooting in Southaven
October 10, 2022 | bizjournals.com
Pam Marrone starts new company, Invasive Species Control Corp., to battle farm, forest and waterway pests
October 10, 2022 | americanbankingnews.com
Marrone Bio Innovations (NASDAQ:MBII) Coverage Initiated at StockNews.com
September 28, 2022 | msn.com
MBI: Body found in Forrest Co. identified
September 28, 2022 | benzinga.com
The agriculture microbial market is projected to reach US$ 18,003.75 million by 2028 from US$ 6,901.93 million in 2021
September 28, 2022 | marketwatch.com
Crop Protection Chemicals Market Size to Grow at 4.35% CAGR During the Forecast Period of 2022-2027 | 125 Report Pages
September 25, 2022 | finance.yahoo.com
Conceptual Innovations' HaloDrive delivers precision and maneuverability while carrying heavy loads
July 13, 2022 | finance.yahoo.com
Marrone name goes away in sale to Bioceres
June 27, 2022 | apnews.com
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates GRRB, MBII, EMCF, MN
June 16, 2022 | finance.yahoo.com
BIOX: Bioceres Crop Solutions Granted Approval by China to Import HB4 Soy for Food & Feed. HB4 Soy & HB4 Wheat expected to generate incremental EBITDA between $35 million and $45 million in fiscal 2025.
June 3, 2022 | finance.yahoo.com
AgStart seeks support to expand critical startup lab space in Woodland
May 17, 2022 | finance.yahoo.com
Marrone Bio's (MBII) Earnings and Revenues Miss Estimates in Q1
May 11, 2022 | seekingalpha.com
Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q1 2022 Results - Earnings Call Transcript
May 11, 2022 | finance.yahoo.com
Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results
May 11, 2022 | finance.yahoo.com
Marrone Bio Innovations, Inc. (MBII) Reports Q1 Loss, Lags Revenue Estimates
May 9, 2022 | ca.proactiveinvestors.com
Water Tower Research publishes report on pending merger between Marrone Bio and Bioceres Crop Solutions
April 29, 2022 | markets.businessinsider.com
Mid-Afternoon Market Update: Nasdaq Down 3%; Accolade Shares Slide
April 27, 2022 | finance.yahoo.com
Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time
April 11, 2022 | finance.yahoo.com
Former Marrone Bio executive Absi sentenced to two years in prison
March 29, 2022 | finance.yahoo.com
Marrone Bio Innovations, Inc. (MBII) Reports Q4 Loss, Tops Revenue Estimates
March 28, 2022 | finance.yahoo.com
Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results
March 25, 2022 | benzinga.com
Preview: Marrone Bio Innovations's Earnings
March 18, 2022 | marketwatch.com
Bioceres, Marrone Bio Innovations To Combine Companies in All-Stock Transaction
See More Headlines

Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

MBII Company Calendar

Last Earnings
11/10/2021
Today
12/06/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Agricultural Chemicals
Sub-Industry
N/A
Sector
Basic Materials
Current Symbol
NASDAQ:MBII
CUSIP
N/A
CIK
1441693
Web
www.marronebioinnovations.com
Phone
(530) 750-2800
Fax
N/A
Employees
153
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$1.30
High Stock Price Forecast
$1.30
Low Stock Price Forecast
$1.30
Forecasted Upside/Downside
+62.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-16,550,000.00
Net Margins
-47.07%
Pretax Margin
-47.12%
Return on Equity
-70.87%
Return on Assets
-25.23%

Debt

Debt-to-Equity Ratio
0.33
Current Ratio
0.79
Quick Ratio
0.55

Sales & Book Value

Annual Sales
$44.31 million
Price / Sales
3.28
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
4.69

Miscellaneous

Outstanding Shares
182,378,000
Free Float
173,259,000
Market Cap
$145.56 million
Optionable
Not Optionable
Beta
0.36

Key Executives

  • Mr. Kevin R. Helash (Age 57)
    CEO & Director
    Comp: $416.64k
  • Dr. Pamela G. Marrone Ph.D. (Age 65)
    Founder, Advisor & Non-Employee Director
    Comp: $254.58k
  • Ms. Linda V. Moore (Age 75)
    Chief Compliance Officer, Chief Legal Officer & Sec.
    Comp: $316.74k
  • Mr. LaDon Johnson CPA
    CPA, Interim Chief Financial Officer
  • Dr. Amit Vasavada Ph.D. (Age 67)
    Sr. VP of Research Devel. & Chief Technical Officer
  • Andre Trepanier
    Director of Marketing
  • Mr. Barner Jones
    Director of National Sales & Account Management
  • Mr. Matti Tiainen (Age 33)
    Sr. VP of International Sales
  • Mr. Keith J. Pitts (Age 58)
    Sr. VP of Regulatory & Gov. Affairs and Chief Sustainability Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













MBII Stock - Frequently Asked Questions

Should I buy or sell Marrone Bio Innovations stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Marrone Bio Innovations in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MBII shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MBII, but not buy additional shares or sell existing shares.
View MBII analyst ratings or view top-rated stocks.

What is Marrone Bio Innovations' stock price forecast for 2023?

1 brokerages have issued 1-year price objectives for Marrone Bio Innovations' shares. Their MBII share price forecasts range from $1.30 to $1.30. On average, they expect the company's share price to reach $1.30 in the next year. This suggests a possible upside of 62.9% from the stock's current price.
View analysts price targets for MBII or view top-rated stocks among Wall Street analysts.

How were Marrone Bio Innovations' earnings last quarter?

Marrone Bio Innovations, Inc. (NASDAQ:MBII) posted its quarterly earnings results on Wednesday, November, 10th. The basic materials company reported ($0.03) EPS for the quarter, hitting the consensus estimate of ($0.03). The basic materials company earned $9.86 million during the quarter, compared to analysts' expectations of $10.79 million. Marrone Bio Innovations had a negative net margin of 47.07% and a negative trailing twelve-month return on equity of 70.87%. During the same quarter in the previous year, the company posted ($0.04) earnings per share.

What other stocks do shareholders of Marrone Bio Innovations own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marrone Bio Innovations investors own include Ekso Bionics (EKSO), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), KushCo (KSHB), Enerplus (ERF), ADMA Biologics (ADMA), Great Panther Mining (GPL), OrganiGram (OGI), Aeterna Zentaris (AEZS).

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

What is Marrone Bio Innovations' stock price today?

One share of MBII stock can currently be purchased for approximately $0.80.

How much money does Marrone Bio Innovations make?

Marrone Bio Innovations (NASDAQ:MBII) has a market capitalization of $145.56 million and generates $44.31 million in revenue each year. The basic materials company earns $-16,550,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.

How many employees does Marrone Bio Innovations have?

The company employs 153 workers across the globe.

How can I contact Marrone Bio Innovations?

Marrone Bio Innovations' mailing address is 1540 Drew Avenue, Davis CA, 95618. The official website for the company is www.marronebioinnovations.com. The basic materials company can be reached via phone at (530) 750-2800 or via email at ir@marronebio.com.

This page (NASDAQ:MBII) was last updated on 12/6/2022 by MarketBeat.com Staff